Nearing a COVID-19 vaccine approval in China, Fosun gears up to launch BioNTech shot: report

China’s approval of the mRNA COVID-19 vaccine developed by BioNTech appears likely within the next few months and thanks to a deal made between the biotech and China’s Fosun Pharma, the shot will be ready for production and distribution almost immediately, a source told Global Times.